Free Trial
OTCMKTS:BTCY

Biotricity (BTCY) Stock Price, News & Analysis

Biotricity logo
$0.36
-0.05 (-12.27%)
(As of 11/4/2024 ET)

About Biotricity Stock (OTCMKTS:BTCY)

Key Stats

Today's Range
$0.36
$0.42
50-Day Range
$0.20
$0.57
52-Week Range
$0.19
$1.67
Volume
135,217 shs
Average Volume
76,398 shs
Market Capitalization
$8.08 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.

Biotricity Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
9th Percentile Overall Score

BTCY MarketRank™: 

Biotricity scored higher than 9% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Biotricity is -0.21, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Biotricity is -0.21, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Percentage of Shares Shorted

    1.09% of the outstanding shares of Biotricity have been sold short.
  • Short Interest Ratio / Days to Cover

    Biotricity has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Biotricity has recently increased by 11.18%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Biotricity does not currently pay a dividend.

  • Dividend Growth

    Biotricity does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.09% of the outstanding shares of Biotricity have been sold short.
  • Short Interest Ratio / Days to Cover

    Biotricity has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Biotricity has recently increased by 11.18%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Biotricity has a news sentiment score of 0.71. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.45 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Biotricity this week, compared to 0 articles on an average week.
  • Search Interest

    Only 1 people have searched for BTCY on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Biotricity insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    10.10% of the stock of Biotricity is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 3.89% of the stock of Biotricity is held by institutions.

  • Read more about Biotricity's insider trading history.
Receive BTCY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biotricity and its competitors with MarketBeat's FREE daily newsletter.

BTCY Stock News Headlines

Blackrock’s Sending THIS Crypto Higher on Purpose
It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…
Biotricity Inc BTCY
Biotricity's Earnings Outlook
See More Headlines

BTCY Stock Analysis - Frequently Asked Questions

Biotricity's stock was trading at $1.15 at the beginning of the year. Since then, BTCY shares have decreased by 68.9% and is now trading at $0.3574.
View the best growth stocks for 2024 here
.

Biotricity, Inc. (OTCMKTS:BTCY) released its earnings results on Monday, August, 19th. The company reported ($0.49) EPS for the quarter. The business had revenue of $3.20 million for the quarter.

Shares of Biotricity reverse split before market open on Monday, July 3rd 2023. The 1-6 reverse split was announced on Monday, July 3rd 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, July 3rd 2023. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split.

Shares of BTCY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Biotricity investors own include NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), Broadcom (AVGO), Micron Technology (MU) and Bank of America (BAC).

Company Calendar

Last Earnings
8/19/2024
Today
11/04/2024
Fiscal Year End
3/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Devices
Sub-Industry
Medical Equipment
Current Symbol
OTCMKTS:BTCY
Fax
N/A
Employees
40
Year Founded
N/A

Profitability

Net Income
$-18,660,000.00
Net Margins
-163.11%
Pretax Margin
-163.11%

Debt

Sales & Book Value

Annual Sales
$12.06 million
Book Value
($2.67) per share

Miscellaneous

Free Float
6,963,000
Market Cap
$8.08 million
Optionable
Not Optionable
Beta
1.33
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (OTCMKTS:BTCY) was last updated on 11/5/2024 by MarketBeat.com Staff
From Our Partners